Thailand Medical Cannabis Market is expected to grow with the CAGR of 25.16% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
Access Full Report @ https://www.databridgemarketresearch.com/reports/thailand-medical-cannabis-market
Thailand medical cannabis market is a highly consolidated market, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Thailand medical cannabis market are introducing strong range of product portfolio. This helped companies to maximize the sales with enhanced product portfolio.
For instance,
- In December 2020, Tilray announced that it has successfully exported extracts of medical cannabis from its GMP certified production facility to patients in use. This will help the company to expand its business.
Tilray is the dominating player in Thailand Medical Cannabis market. The other key players existing in the market includes MediPharm Labs, Inc., Elixinol Thailand Limited, Medical Marijuana, Inc., Extractas, Peace Naturals Project Inc., BOL Pharma, PharmaHemp, Kiehl’s (A Subsidiary of L'ORÉAL), CANOPY GROWTH CORPORATION, Cresco Labs, Aurora Cannabis, Althea Company Pty Ltd (A Subsidiary of Althea Group Holdings Limited), IDT Australia, MediPharm Labs Inc., THC Thailand Group Limited, and Aphria Inc. among others.
Tilray
Tilray is headquartered in Canada which was established in 2018. The company is focused on cannabis research, cultivation, processing and distribution. The company offers wide range of product categories such as medical cannabis, and accessories among which medical cannabis is the market focused category.
- In January 2020, Tilray announced that it has entered into agreement with Canndoc ltd. To export a wholesale shipment of up to 2.5 tonnes of medical cannabis from Portugal to Israel. This will help the company to gain the market
The company has a presence in North America, Europe, South America, Asia-Pacific, Middle East and Africa.
Aurora Cannabis
Aurora Cannabis is headquartered in Alberta, Canada, which was founded in year 2014. The company is focused on medical cannabis, advancing patient access globally and dedicated to helping people improve their health, wellness and overall quality of call. The company offers various product categories such as Cannimed, MedReleaf, Aurora, WMMC, Daily Special, Altavie among which Cannimed, MedReleaf, Aurora, and WMMC are the market focused categories.
- In January 2021, Aurora Cannabis announced that it has entered into an agreement with MedReleaf in which MedReleaf Australia act as the exclusive supplier in Australia of MedReleaf, CanniMed and Aurora brands which includes products from dried flower, oils and softgels. This will help the company to improve the revenue.
The company has presence in North America, Europe, South America, Asia-Pacific, and Middle East and Africa.
CANOPY GROWTH CORPORATION
Canopy Growth Corporation is headquartered in Ontario, Canada which was founded in 2014. The company is engaged in the manufacturing and distribution of medical cannabis products by selling widest variety of seeds in legal sector. The company has product categories which are edibles, beverages, vapes, dried flowers, oils & concentrates, soft gels capsules, and hemp in which edibles, vapes, dried flowers, oils & concentrates, and soft gels capsules are the market focused categories.
- In January 2021, Canopy Growth Corporation announced the opening of nine retail franchised cannabis location across Ontario. This will help the company in addressing the consumer demands and in improving the sales.
The company has wide presence in North America, Europe, South America, Asia-Pacific, and Middle East and Africa.
